Two injections a year helped with rhinosinusitis with nasal polyps.
An international scientific team reported the success of a phase III clinical trial of depemokimab for chronic rhinosinusitis with nasal polyps. This monoclonal antibody to interleukin-5 is administered semiannually. The report…